Edition:
United Kingdom

Joincare Pharmaceutical Group Industry Co Ltd (600380.SS)

600380.SS on Shanghai Stock Exchange

11.15CNY
15 Dec 2017
Change (% chg)

¥-0.52 (-4.46%)
Prev Close
¥11.67
Open
¥11.60
Day's High
¥11.60
Day's Low
¥11.10
Volume
33,760,190
Avg. Vol
34,585,240
52-wk High
¥13.99
52-wk Low
¥8.10

Latest Key Developments (Source: Significant Developments)

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says its unit received drug clinical trial approval for Recombinant Humanized anti-PD-1 Monoclonal Antibody for Injection .  Full Article

Joincare Pharmaceutical Group Industry unit receives approval for drug clinical trial
Friday, 3 Nov 2017 

Nov 3(Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says co's Zhuhai-based biotechnology unit received approval for drug clinical trial, regarding recombinant humanized anti-PD-1 monoclonal antibody for injection, from China Food and Drug Administration.  Full Article

Joincare Pharmaceutical Group Industry sees FY 2017 net profit up 337.2 pct to 370.3 pct
Friday, 27 Oct 2017 

Oct 27 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says it sees net profit for FY 2017 to increase 337.2 percent to 370.3 percent, or to be 1.97 billion yuan to 2.12 billion yuan.Says the net profit of FY 2016 was 451.4 million yuan.Comments that sale of unit as main reason for the forecast .  Full Article

Joincare Pharmaceutical Group's 9-month net profit up 441.9 pct y/y
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says 9-month net profit up 441.9 percent y/y.  Full Article

Joincare Pharmaceutical Group Industry units get drug clinical trial approval for Tobramycin Inhalation Solution
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS> ::Says its units and partners get drug clinical trial approval for Tobramycin Inhalation Solution.  Full Article

Joincare Pharmaceutical expects 9-month net profit to rise to 2.0-2.1 bln yuan
Friday, 13 Oct 2017 

Oct 13 (Reuters) - Joincare Pharmaceutical Group Industry Co Ltd <600380.SS>:Says it expects 9-month net profit to rise to 2.0-2.1 billion yuan from 373.8 million yuan ($56.76 million) year ago.  Full Article

Livzon Pharmaceutical Group units receive approval for drug clinical trials
Monday, 18 Sep 2017 

Sept 18 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:* Says its units received drug clinical trials approval for drug, Triptorelin Acetate Microspheres for Injection.  Full Article

Joincare Pharmaceutical Group Industry issues 600 mln yuan worth of commercial paper
Monday, 8 Aug 2016 

Joincare Pharmaceutical Group Industry Co., Ltd. <600380.SS>: Says it issues first tranche of 2016 super short-term financing bills worth 600 million yuan . Says the bills with a term of 270 days and an interest rate of 2.8 percent .Says the maturity date of May 1, 2017.  Full Article

Joincare Pharmaceutical Group Industry to pay 2015 dividend on July 6
Tuesday, 28 Jun 2016 

Joincare Pharmaceutical Group Industry Co., Ltd. <600380.SS>: Says it will pay cash dividend of 0.1 yuan per share (before tax) for 2015 to shareholders of A shares of record on July 5 .Says the company's shares will be traded ex-right and ex-dividend on July 6 and the dividend will be paid on July 6.  Full Article

Joincare Pharmaceutical Group Industry unit gets nod for clinic trial
Saturday, 9 Apr 2016 

Joincare Pharmaceutical Group Industry Co Ltd:Says its unit gets China Food and Drug Administration's approval for its budesonide aerosol inhalation's clinic trial.  Full Article